SCHEMBL20726017

SCHEMBL20726017

C/C=N\c1cc(C)ccc1C

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 1/20 0.49
MAPT P10636 10/20 0.44
KDM4E B2RXH2 6/20 0.44
HTT P42858 5/20 0.44
LMNA P02545 4/20 0.44
CYP3A4 P08684 1/20 0.42
ADRA2A P08913 1/20 0.42
ALDH1A1 P00352 6/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
TDP1 Q9NUW8 4/20 0.39
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
POLB P06746 2/20 0.39
BLM P54132 1/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 3/20 0.38
GAA P10253 2/20 0.38
RAPGEF4 Q8WZA2 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.35
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21131297 0.82 CYP3A4 (0.62) MAPTKDM4EHTTLMNACYP3A4
SCHEMBL8292092 0.82 CYP3A4 (0.62) MAPTKDM4EHTTLMNACYP3A4
SCHEMBL20663205 0.80 DHODH (0.47) DHODHMAPTKDM4EHTTLMNA
SCHEMBL20663401 0.78 MAPT (0.53) DHODHMAPTKDM4EHTTLMNA
SCHEMBL18874808 0.78 MAPT (0.42) DHODHMAPTKDM4EHTTLMNA
SCHEMBL23969176 0.78 MAPT (0.53) DHODHMAPTKDM4EHTTLMNA
SCHEMBL16130312 0.78 MAPT (0.42) DHODHMAPTKDM4EHTTLMNA
SCHEMBL23750192 0.78 CYP3A4 (0.37) DHODHMAPTKDM4EHTTLMNA
SCHEMBL22991960 0.77 MAPT (0.49) DHODHMAPTKDM4EHTTLMNA
SCHEMBL19017627 0.77 KDM4E (0.41) DHODHMAPTKDM4EHTTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4085059-B1 HETEROARYL COMPOUNDS AS INHIBITORS OF PROGRAMMED NECROSIS PATHWAY, COMPOSITION AND METHOD USING THE SAME ACCRO BIOSCIENCE HK LTD (HK) 2024-03-20 EP disclosed
EP-3582783-B1 7-MEMBERED AZA-HETEROCYCLIC CONTAINING DELTA-OPIOID RECEPTOR MODULATING COMPOUNDS, METHODS OF USING AND MAKING THE SAME TREVENA INC (US) 2023-06-07 EP disclosed
WO-2022003575-A1 HER2 MUTATION INHIBITORS ARRAY BIOPHARMA INC. (US) 2022-01-06 WO disclosed
WO-2020252407-A1 ACETYL-COA SYNTHETASE 2 (ACSS2) INHIBITORS AND METHODS USING SAME THE WISTAR INSTITUTE (US) 2020-12-17 WO disclosed
EP-3744714-A1 (2S)-N-[(1S)-1-CYANO-2-PHENYLETHYL]-1,4-OXAZEPANE-2-CARBOXAMIDES AS DIPEPTIDYL PEPTIDASE I INHIBITORS Astrazeneca AB (SE) 2020-12-02 EP disclosed
EP-3441389-A1 PYRAZOLE-OXAZOLIDINONE COMPOUND FOR ANTI-HEPATITIS B VIRUS Shanghai Zhimeng Biopharma Co., Ltd (CN) 2019-02-13 EP disclosed